Navitus to Remove Humira from Formularies June 1

Navitus to Remove Humira® from Formularies Effective June 1

More than ten biosimilars to Humira® were launched in 2023, introducing price competitiveness for one of the most utilized drugs on the market....

Read More
Industry News, Specialty

Humira Biosimilars – Update for October Formularies

Our recent August Pharmacy and Therapeutics (P&T) Committee meeting reviewed the release of various Humira® biosimilars. Staying true to our...

Read More
Industry News, Specialty

Legal Ease: A Navitus Government Affairs Update

In an ever-changing legislative landscape, we want to help our clients and partners stay informed of the latest happenings and how proposed policies...

Read More
Industry News

Humira Biosimilars – Summer of Blockbuster Releases for Navitus to Review

This summer has seen a continuation of the long-awaited market entry of Humira® (adalimumab) biosimilars. As of July 1, nine additional biosimilars...

Read More
Industry News, Specialty

Transforming Access to Pharmacy Benefits: 2022 Drug Trend Report

We are pleased to share our 2022 Drug Trend Report with you. This year's report highlights our success in managing pharmacy benefit costs for our...

Read More
Industry News

Humira Biosimilars Enter the Marketplace – Update on Navitus’ Review

The market entry of biosimilars to Humira® (adalimumab) is long-awaited. These products have the potential to improve affordability in the near- and...

Read More
Industry News, Specialty

Five Forecasts and Takeaways for Plan Sponsors in 2023

As we enter 2023, David Fields is sharing his top forecasts and takeaways for plan sponsors and the PBM industry.

Read More
Industry News, Specialty
Inflation Reduction Act of 2022

Understanding the Inflation Reduction Act of 2022

Navitus’ Vice President of Government Relations, Robyn Crosson, shares her insight into the Inflation Reduction Act and how it will impact our...

Read More
Industry News

Key Findings: 2021 Navitus Drug Trend Report

This week we provide an overview of our 2021 drug trend and client savings with insights for 2022 and beyond.

Read More
Industry News

What You Need to Know About Fraud, Waste and Abuse in The Age of COVID-19

Carrie Aiken, Navitus’ Vice President of Corporate Compliance and Chief Compliance Officer, shares her perspective on how PBMs can help plan sponsors...

Read More
Industry News

Building Specialty Pharmacy Success

Sharon Faust, PharmD, Vice President of Specialty Pharmacy for Lumicera shares a few key initiatives that will continue to create an impact for...

Read More
Industry News, Specialty

Know Your Options for At-Home COVID-19 Test Kits

As a member, plan sponsor or consultant, do you understand what the new federal guidance on free at-home COVID-19 tests means to you? As part of...

Read More
Industry News, Member

Recent Posts